Methods: This prospective, randomized, double-blinded study was performed between 1 February 2008 and 1 December 2008. A total of 20 ASA III-IV patients (12 males, 8 females; mean age 59.35; range 18 to 69 years) who underwent coronary artery bypass graft surgery, were included in either the Levobupivacaine group (Group LB, n=11) or Placebo group (Group P, n=9). Group LB patients received 0.25% levobupivacaine (1.35 mg/kg) locally infiltrated in both sides of the sternum in addition to routine procedures. The placebo group received no additional local anesthesia. Postoperative verbal rating skala (VRS) scores, morphine consumption and pulmonary functions were evaluated in all patients.
Results: Less complaints and lower VRS scores were observed in group LB compared to group P at different hours following extubation (p<0.05). Significantly lower 24-hour morphine consumption was found in group LB compared with group P (p<0.001). Significant decreases were recorded in pulmonary functions after surgery in both groups, however decreasing amounts of pulmonary function were not different between the two groups (p>0.05).
Conclusion: Parasternal block and local infiltration using levobupivacaine was effective for decreasing postoperative pain, however levobupivacaine was inefficient for prevention of pulmonary function deterioration following surgery. Further studies with more patients are needed to elucidate this topic.
Parasternal block and local anesthetic infiltration around the sternum may be useful in providing early postoperative analgesia even in anticoagulated patients. Regional anesthetic blocks are useful alternative methods in decreasing opioid needs and side effects such as respiratory depression and sedation. However their beneficial effects have rarely been reported.[5,6] Therefore, the aim of the present study was to investigate whether peroperative parasternal block with levobupivacaine had a favorable effect on postoperative pain and respiratory functions in patients undergoing off-pump coronary artery bypass graft (OPCABG) surgery.
During preoperative evaluation the day before surgery, information was given to patients about verbal rating skala (VRS), PCA and bedside spirometry device. We used a portable “Respiradyne II” (Manufacturer, Location (Sherwood Medical; St. Louis, MO) bedside spirometry device for measurement of FEV1, FVC, FEV1/FVC values. All patients were premedicated with midazolam, 0.05 mg/kg intramuscular (i.m), 45 min before the surgical procedure. In the operation room before induction and during surgery, all parameters including heart rate, ST-segment analysis and blood pressure were recorded using Datex Ohmeda S/5 (manufacturer, location (Datex-Ohmeda Division, Instrumentarium Corp., Helsinki, Finland) monitor.
Anesthesia was induced with etomidate (0.3 mg/kg i.v), fentanyl (2 μg/kg i.v) and rocuronium (0.9 mg/kg i.v), and was initially maintained with desflurane 5-8% inspired in combination with oxygen 50% in air.
The patients were randomly allocated into two groups according to computer-generated randomization. At the end of the surgery, before sternal closure, administration of 0.25% levobupivacain, 1.35 mg/kg, 50 ml (bilateral 5 costal levels and every level 2 ml, on both sides of the sternum over periosteum 20 ml and at the entrance of chest tubes, deep infiltration 10 ml) was performed in group LB (levobupivacain) patients. Group P (Placebo) patients received a total 50 ml saline (bilateral 5 costal levels and every level 2 ml, on both sides of the sternum over periosteum 20 ml and at the entrance of chest tubes, deep infiltration 10 ml).[5] All the staff in the operating room was unaware of the randomization and drugs were prepared by an investigator who was also blinded.
At the end of surgery, all anesthetics were discontinued and patients were transferred to the ICU where they were commited to a mechanical ventilator. In ICU, electrocardiography (ECG), peripheral oxygen saturation, invasive arterial pressure and central venous pressure were monitored.
During follow-up in ICU patients who had the following characteristics were extubated and extubation times were recorded;
1- Being fully conscious, obeying verbal commands,
2- Systolic arterial pressure ≥90 mmHg and stable
cardiac rhythm,
3- No active bleeding,
4- VRS score ≤5,
5- SpO2 ≥95 when 50% air-oxygene,
6- Respiratory rate 10-30/minutes,
7- Arterial pH ≥7.25, PCO2 ≤55 mm/Hg.
Duration between ICU admission and extubation moment was accepted as ”extubation time”.
All the patients included in our study received morphine sulphate infusion with intravenous-PCA device (Abbott APM) for postoperative analgesia after extubation. Patient controlled analgesia device was set to deliver 2 mg/i.v bolus injections of morphine at a lockout interval of 15 min and with a maximum four hours limit of 24 mg. The incremental bolus dose of morphine was increased to 3 mg if analgesia was inadequate (VRS pain score >5) after the first hour of PCA use. During postoperative 24 hour follow up; we recorded resting VRS scores and morphine consumption at 1st, 2nd, 3rd, 4th, 8th, and 24th hours. We also recorded FEV1, FVC, FEV1/FVC values measured by portable spirometry device at 6th, 12th, and 24th hours after extubation. All data were collected by an investigator who was also blinded.
Statistical analysis
Initial sample size estimation showed that approximately
17 patients were needed in each group to detect
reduction of morphine consumption by 25% with a
power of 0.80 and a level of significance of 5%. We used
SPSS 13.0 version (SPSS Inc., Chicago, Illinois, USA)
program for statistical analysis. Demographic data were
evaluated by “descriptive statistical methods”. Peri- and
postoperative vital signs and VRS pain scores were
compared by “Mann-Whitney U-test”. Twenty-fourhour
total morphine consumption in two groups was
compared using “repeated measures variance analysis”.
Bedside pulmonary function tests were analyzed both
within-groups and inter-groups using by “two-way variance
analysis”. Results were assessed at 95% confidence interval. A p value of less than 0.05 was accepted as
statistically significant.
Table 1: Demographic characteristics of the patients (Mean±SD)
Fig 1: Mean verbal rating skala scores. LB: Levobupivacain; P: Placebo; *: p<0.05.
Distribution of 24-hour-morphine consumption in groups LB and P are seen in table 2. At all measurement time intervals, morphine consumptions were statistically lower in group LB than group P (p<0.001).
Table 2: The comparison of morphin consumption (mg) between two groups (Mean±SD)
When pulmonary functions were evaluated, significant decreases were found in FEV1 and FVC at 6th, 12th and 24th hours compared with preoperative “first measurements” in both LB and P groups. The decreased FEV1 a nd F VC values a s l iters ( L) a nd p ercentage (%) is shown in table 3. There were no significant differences in decreases of FEV1 and FVC between the two groups (p>0.05).
Table 3: Changes of pulmonary function tests between groups
Mean intubation time and mean extubation times were statistically shorter in group LB than group P (288±18 minutes vs. 359±44 minutes respectively, p<0.001; 119±20 minutes vs. 198±10 minutes, respectively, p<0.001).
Elective CABG may lead to pain due to median sternotomy and chest tube entrance incisions. These patients may also suffer from immobility, insufficient ventilation and inability to cough. Therefore, their weaning from mechanical ventilation may be delayed and the duration of stay in the ICU and hospital may be lengthened. For these reasons, accelerating extubation with effective analgesic methods and drugs will be the main target.[8]
For OPCABG surgery patients; i.v opioids, intrathecal morphine and epidural analgesia are used as classical analgesic methods. However, most anesthetists avoid epidural methods because of potential hematoma development risk.[5] Intravenous opioid therapy is often used for postoperative analgesia. Although intravenous opioids are very effective, their use is being restricted due to respiratory depression.[9]
Levobupivacaine; is a long acting, less cardiotoxic local anesthetic with less central nervous system (CNS) side effects. The dose used for parasternal block and local infiltration is 1.35 mg/kg which is under the toxic dose (277±51 mg).[10,11] Infiltration of surgical wounds has been reported to enhance postoperative analgesia after various procedures such as upper abdominal surgery,[12] open cholecystectomy,[13] abdominal hysterectomy,[14] caesarean section[15] a nd i nguinal h erniotomy.[16] Ng et al.[17] performed local infiltration of levobupivacaine + ephedrine in laparoscopic cholesystectomy, intraperitoneally and around the incision site; the levobupivacaine group had significantly lower VRS scores than the placebo group. Morphine consumption was also lower than placebo. Another study performed in laparoscopic gynecologic surgery reported that preoperative local levobupivacaine infiltration significantly decreased postoperative wound pain, average VRS scores and analgesic consumption.[18] P apagiannopoulou et al.[19] performed local infiltration of levobupivacaine and ropivacaine before incision in laparoscopic cholesystectomy; the levobupivacaine group had significantly lower VRS scores and morphine consumption. In our study, the parasternal block was performed by local levobupivacaine infiltration at the end of surgery; this method is also easy, simple and safe like local anesthetic infiltration before surgery.
Other than parasternal block and local infiltration with levobupivacaine after surgery, the effectiveness of intercostal block and thoracic epidural analgesia have also been investigated in thoracic surgery. Concha et al.[20] compared two groups usingintercostal block and thoracic epidural methods on posterolateral thoracotomy patients. They used 0.5% levobupivacaine as local anesthetic together with intravenous morphine. One day before operation, basal FEV1 and FVC values were measured. Postoperative 1st, 2nd, 3rd, 4th, 12th, and 24th hour dynamic and resting VRS scores were recorded. Postoperative FEV1 and FVC values were decreased 60% with respect to the basal values and inter-group differences of decrease were not statistically significant. In the study of McDonald et al.,[5] 24-hour-morphine consumption has been found significantly lower after parasternal block and local infiltration by levobupivacaine in patients undergoing cardiac surgery under desflurane anesthesia. Although parasternal block and local infiltration decreased the pain, pulmonary function tests (FEV1 and FVC) were still impaired. The decreased ratio of pulmonary function tests (FEV1 and FVC) were 50-55% according to preoperative “first measure” values, and these ratios were similar for both levobupivacaine and control groups.[5] In our OPCABG study, owing to the levobupivacaine parasternal block technique, extubation times were significantly shorter than the control group. Thereby lesser opioid need and less sedation were seen and ICU stay was also significantly shorter. However, according to our results, parasternal block and local infiltration of LB could not prevent impairment of pulmonary function tests, since significant decreases of pulmonary function tests were found in both groups FEV1 and FVC values were 55-60% lower than preoperative values after surgical operation. It is not enough to explain impaired FEV1 and FVC only with pain.[21] Other reasons of impaired pulmonary functions may be deterioration in chest wall integrity after sternotomy and irritation of free edges of chest drains on deep inspiration. Even if the patients are painless with morphine infusion, they might be afraid of taking deep breaths. These reasons are suggested to cause impaired spirometry values.[22] After operations like cardiac surgery, where the thorax is opened, FEV1 and FVC will inevitably decrease.
In conclusion, parasternal block and local anesthetic infiltration with levobupivacaine decreased postoperative pain and shortened extubation time in our study group. However, it could not prevent postoperative impairment of pulmonary function. In order to enlucidate this topic, further studies with larger study groups are needed.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect
to the authorship and/or publication of this article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Cheng DC, Karski J, Peniston C, Asokumar B, Raveendran
G, Carroll J, et al. Morbidity outcome in early versus conventional
tracheal extubation after coronary artery bypass
grafting: a prospective randomized controlled trial. J Thorac
Cardiovasc Surg 1996;112:755-64.
2) Higgins TL. Pro: early endotracheal extubation is preferable
to late extubation in patients following coronary artery surgery.
J Cardiothorac Vasc Anesth 1992;6:488-93.
3) Mueller XM, Tinguely F, Tevaearai HT, Revelly JP, Chioléro
R, von Segesser LK. Pain location, distribution, and intensity
after cardiac surgery. Chest 2000;118:391-6.
4) Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery:
a prospective cohort study of 1-year incidence and intensity.
Anesthesiology 2006;105:794-800.
5) McDonald SB, Jacobsohn E, Kopacz DJ, Desphande S,
Helman JD, Salinas F, et al. Parasternal block and local
anesthetic infiltration with levobupivacaine after cardiac
surgery with desflurane: the effect on postoperative pain,
pulmonary function, and tracheal extubation times. Anesth
Analg 2005;100:25-32.
6) Chaney MA. How important is postoperative pain after cardiac
surgery? J Cardiothorac Vasc Anesth 2005;19:705-7.
7) Power I. Recent advances in postoperative pain therapy. Br J
Anaesth 2005;95:43-51.
8) Montes FR, Sanchez SI, Giraldo JC, Rincón JD, Rincón IE,
Vanegas MV, et al. The lack of benefit of tracheal extubation
in the operating room after coronary artery bypass surgery.
Anesth Analg 2000;91:776-80.
9) Coriat P, Beaussier M. Fast-tracking after coronary artery
bypass graft surgery. Anesth Analg 2001;92:1081-3.
10) McLeod GA, Gennery BA, Brennan NE. Levobupivacaine:
improved safety for obstetric anesthesia. Adv Anesth 2001;18;
65-6.
11) McLeod GA, Burke D. Levobupivacaine. Anaesthesia 2001;
56:331-41.
12) Bartholdy J, Sperling K, Ibsen M, Eliasen K, Mogensen T.
Preoperative infiltration of the surgical area enhances postoperative
analgesia of a combined low-dose epidural bupivacaine
and morphine regimen after upper abdominal surgery.
Acta Anaesthesiol Scand 1994;38:262-5.
13) Johansson B, Glise H, Hallerbäck B, Dalman P, Kristoffersson
A. Preoperative local infiltration with ropivacaine for postoperative
pain relief after cholecystectomy. Anesth Analg
1994;78:210-4.
14) Hannibal K, Galatius H, Hansen A, Obel E, Ejlersen E.
Preoperative wound infiltration with bupivacaine reduces
early and late opioid requirement after hysterectomy. Anesth
Analg 1996;83:376-81.
15) Bamigboye AA, Hofmeyr GJ. Local anaesthetic wound infiltration
and abdominal nerves block during caesarean section
for postoperative pain relief. Cochrane Database Syst Rev
2009:CD006954.
16) Dierking GW, Ostergaard E, Ostergård HT, Dahl JB. The
effects of wound infiltration with bupivacaine versus saline
on postoperative pain and opioid requirements after herniorrhaphy.
Acta Anaesthesiol Scand 1994;38:289-92.
17) Ng A, Swami A, Smith G, Robertson G, Lloyd DM. Is
intraperitoneal levobupivacaine with epinephrine useful for
analgesia following laparoscopic cholecystectomy? A randomized
controlled trial. Eur J Anaesthesiol 2004; 21:653-7.
18) Alessandri F, Lijoi D, Mistrangelo E, Nicoletti A, Ragni N.
Effect of presurgical local infiltration of levobupivacaine
in the surgical field on postsurgical wound pain in laparoscopic
gynecological surgery. Acta Obstet Gynecol Scand
2006;85:844-9.
19) Papagiannopoulou P, Argiriadou H, Georgiou M, Papaziogas B, Sfyra E, Kanakoudis F. Preincisional local infiltration of
levobupivacaine vs ropivacaine for pain control after laparoscopic
cholecystectomy. Surg Endosc 2003;17:1961-4.
20) Concha M, Dagnino J, Cariaga M, Aguilera J, Aparicio R,
Guerrero M. Analgesia after thoracotomy: epidural fentanyl/
bupivacaine compared with intercostal nerve block
plus intravenous morphine. J Cardiothorac Vasc Anesth
2004;18:322-6.